Are in vivo studies needed in the safety assessment of biosimilars? A regulatory perspective
Year: 2016
Type: article
Source: Toxicology Letters
Author: L. van Aerts
Institution: Medicines Evaluation Board
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2534371925